-
1
-
-
47949129901
-
Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation
-
S. Agatonovic-Kustrin, B.D. Glass, M. Mangan, and J. Smithson Analysing the crystal purity of mebendazole raw material and its stability in a suspension formulation Int. J. Pharm. 361 2008 245 250
-
(2008)
Int. J. Pharm.
, vol.361
, pp. 245-250
-
-
Agatonovic-Kustrin, S.1
Glass, B.D.2
Mangan, M.3
Smithson, J.4
-
3
-
-
77951498256
-
Characterization and stability of solid dispersions based on PEG/polymer blends
-
H. Bley, B. Fussnegger, and R. Bodmeier Characterization and stability of solid dispersions based on PEG/polymer blends Int. J. Pharm. 390 2010 165 173
-
(2010)
Int. J. Pharm.
, vol.390
, pp. 165-173
-
-
Bley, H.1
Fussnegger, B.2
Bodmeier, R.3
-
4
-
-
67649672107
-
Characterization and in vitro release of praziquantel from poly (-caprolactone) implants
-
L. Cheng, S. Guo, and W. Wu Characterization and in vitro release of praziquantel from poly (-caprolactone) implants Int. J. Pharm. 377 2009 112 119
-
(2009)
Int. J. Pharm.
, vol.377
, pp. 112-119
-
-
Cheng, L.1
Guo, S.2
Wu, W.3
-
5
-
-
0035376188
-
Efficacy of flubendazole and albendazole against Trichinella spiralis in mice
-
M.S. Chung, K.H. Joo, F.S. Quan, H.S. Kwon, and S.W. Cho Efficacy of flubendazole and albendazole against Trichinella spiralis in mice Parasite 8 Suppl. 2 2001 S195 S198
-
(2001)
Parasite
, vol.8
, Issue.SUPPL. 2
-
-
Chung, M.S.1
Joo, K.H.2
Quan, F.S.3
Kwon, H.S.4
Cho, S.W.5
-
6
-
-
1442299827
-
The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs
-
K. Daniel-Mwambete, Torrado Susana, C. Cuesta-Bandera, F. Ponce-Gordo, and J.J. Torrado The effect of solubilization on the oral bioavailability of three benzimidazole carbamate drugs Int. J. Pharm. 272 2004 29 36
-
(2004)
Int. J. Pharm.
, vol.272
, pp. 29-36
-
-
Daniel-Mwambete, K.1
Susana, T.2
Cuesta-Bandera, C.3
Ponce-Gordo, F.4
Torrado, J.J.5
-
7
-
-
19544391084
-
Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole
-
M.M. De Villiers, R.J. Terblanche, W. Liebenberg, E. Swanepoel, T.G. Dekker, and M. Songa Variable-temperature X-ray powder diffraction analysis of the crystal transformation of the pharmaceutically preferred polymorph C of mebendazole J. Pharm. Biomed. Anal. 38 2005 435 441
-
(2005)
J. Pharm. Biomed. Anal.
, vol.38
, pp. 435-441
-
-
De Villiers, M.M.1
Terblanche, R.J.2
Liebenberg, W.3
Swanepoel, E.4
Dekker, T.G.5
Songa, M.6
-
8
-
-
75449093807
-
Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol® dispersing
-
J.C. DiNunzio, C. Brough, J.R. Hughey, D.A. Miller, R.O. Williams III, and J.W. McGinity Fusion production of solid dispersions containing a heat-sensitive active ingredient by hot melt extrusion and Kinetisol® dispersing Eur. J. Pharm. Biopharm. 74 2010 340 351
-
(2010)
Eur. J. Pharm. Biopharm.
, vol.74
, pp. 340-351
-
-
Dinunzio, J.C.1
Brough, C.2
Hughey, J.R.3
Miller, D.A.4
Iii, O.W.R.5
McGinity, J.W.6
-
9
-
-
17444370493
-
Diclofenac salts, II. Solid dispersions in PEG6000 and Gelucire 50/13
-
A. Fini, J.R. Moyano, J.M. Ginés, J.I. Perez-Martinez, and A.M. Rabasco Diclofenac salts, II. Solid dispersions in PEG6000 and Gelucire 50/13 Eur. J. Pharm. Biopharm. 60 2005 99 111
-
(2005)
Eur. J. Pharm. Biopharm.
, vol.60
, pp. 99-111
-
-
Fini, A.1
Moyano, J.R.2
Ginés, J.M.3
Perez-Martinez, J.I.4
Rabasco, A.M.5
-
11
-
-
0037448408
-
Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole
-
J.J. García, F. Bolás, and J.J. Torrado Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole Int. J. Pharm. 250 2003 351 358
-
(2003)
Int. J. Pharm.
, vol.250
, pp. 351-358
-
-
García, J.J.1
Bolás, F.2
Torrado, J.J.3
-
12
-
-
0035379090
-
Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes
-
J.J. García Rodriguez, J. Torrado, and F. Bolás Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes Parasite 8 2001 S188 S190
-
(2001)
Parasite
, vol.8
-
-
García Rodriguez, J.J.1
Torrado, J.2
Bolás, F.3
-
13
-
-
75449106350
-
Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability
-
Y. Kawabata, K. Yamamoto, K. Debari, S. Onoue, and S. Yamada Novel crystalline solid dispersion of tranilast with high photostability and improved oral bioavailability Eur. J. Pharm. Biopharm. 39 2010 256 262
-
(2010)
Eur. J. Pharm. Biopharm.
, vol.39
, pp. 256-262
-
-
Kawabata, Y.1
Yamamoto, K.2
Debari, K.3
Onoue, S.4
Yamada, S.5
-
14
-
-
0034601240
-
Improving drug solubility for oral delivery using solid dispersions
-
C. Leuner, and J. Dressman Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 50 2000 47 60
-
(2000)
Eur. J. Pharm. Biopharm.
, vol.50
, pp. 47-60
-
-
Leuner, C.1
Dressman, J.2
-
15
-
-
0023841273
-
Comparative efficacy of flubendazole and mebendazole on encysted larvae of Trichinella spiralis (USA strain) in the diaphragm of mice and rats
-
J. Maki, and T. Yanagisawa Comparative efficacy of flubendazole and mebendazole on encysted larvae of Trichinella spiralis (USA strain) in the diaphragm of mice and rats J. Helminthol. 62 1988 35 39
-
(1988)
J. Helminthol.
, vol.62
, pp. 35-39
-
-
Maki, J.1
Yanagisawa, T.2
-
16
-
-
38349100118
-
Enhancement of dissolution rate and bioavailability of aceclofenac: A chitosan-based solvent change approach
-
S. Mutalik, P. Anju, K. Manoj, and A.N. Usha Enhancement of dissolution rate and bioavailability of aceclofenac: a chitosan-based solvent change approach Int. J. Pharm. 350 2008 279 290
-
(2008)
Int. J. Pharm.
, vol.350
, pp. 279-290
-
-
Mutalik, S.1
Anju, P.2
Manoj, K.3
Usha, A.N.4
-
17
-
-
67650450177
-
In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy
-
S. Onoue, H. Sato, Y. Kawabata, T. Mizumoto, N. Hashimoto, and S. Yamada In vitro and in vivo characterization on amorphous solid dispersion of cyclosporine A for inhalation therapy J. Control. Release 138 2009 16 23
-
(2009)
J. Control. Release
, vol.138
, pp. 16-23
-
-
Onoue, S.1
Sato, H.2
Kawabata, Y.3
Mizumoto, T.4
Hashimoto, N.5
Yamada, S.6
-
18
-
-
34047250983
-
Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing
-
K.A. Overhoff, A. Moreno, D.A. Miller, K.P. Johnston, and R.O. Williams III Solid dispersions of itraconazole and enteric polymers made by ultra-rapid freezing Int. J. Pharm. 336 2007 122 132
-
(2007)
Int. J. Pharm.
, vol.336
, pp. 122-132
-
-
Overhoff, K.A.1
Moreno, A.2
Miller, D.A.3
Johnston, K.P.4
Iii, O.W.R.5
-
19
-
-
0023187385
-
Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms
-
F. Rodriguez-Caabeiro, A. Criado-Fornelio, A. Jiménez-Gonzalez, L. Guzmán, A. Igual, A. Pérez, and M. Pujol Experimental chemotherapy and toxicity in mice of three mebendazole polymorphic forms Chemotherapy 33 1987 266 271
-
(1987)
Chemotherapy
, vol.33
, pp. 266-271
-
-
Rodriguez-Caabeiro, F.1
Criado-Fornelio, A.2
Jiménez-Gonzalez, A.3
Guzmán, L.4
Igual, A.5
Pérez, A.6
Pujol, M.7
-
20
-
-
0042932759
-
Efficacy of albendazole against early and late stage of Trichinella spiralis infection in mice
-
P. Siriyasatien, P. Yingyourd, and S. Nuchprayoon Efficacy of albendazole against early and late stage of Trichinella spiralis infection in mice J. Med. Assoc. Thai. 86 Suppl. 2 2003 S257 S262
-
(2003)
J. Med. Assoc. Thai.
, vol.86
, Issue.SUPPL. 2
-
-
Siriyasatien, P.1
Yingyourd, P.2
Nuchprayoon, S.3
-
21
-
-
0037723973
-
Quality evaluation of generic drugs by dissolution test: Changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs
-
E. Swaneppoel, W. Liebenberg, and M.M. Villiers Quality evaluation of generic drugs by dissolution test: changing the USP dissolution medium to distinguish between active and non-active mebendazole polymorphs Eur. J. Pharm. Biopharm. 55 2003 345 349
-
(2003)
Eur. J. Pharm. Biopharm.
, vol.55
, pp. 345-349
-
-
Swaneppoel, E.1
Liebenberg, W.2
Villiers, M.M.3
-
22
-
-
0041510254
-
Differences between USP and BP dissolution results for oxytetracycline capsules after accelerated stability testing
-
E. Swanepoel, W. Liebenberg, and M.M. de Villiers Differences between USP and BP dissolution results for oxytetracycline capsules after accelerated stability testing Pharmazie 58 2003 601 602
-
(2003)
Pharmazie
, vol.58
, pp. 601-602
-
-
Swanepoel, E.1
Liebenberg, W.2
De Villiers, M.M.3
-
23
-
-
75749106962
-
Inulin solid dispersion technology to improve the absorption of the BCS Class IV drug TMC240
-
M.R. Visser, L. Baert, G. Van't Klooster, L. Schueller, M. Geldof, I. Vanwelkenhuysen, H. de Kock, S. De Meyer, H.W. Frijlink, J. Rosier, and W.L.J. Hinrichs Inulin solid dispersion technology to improve the absorption of the BCS Class IV drug TMC240 Eur. J. Pharm. Biopharm. 74 2010 233 238
-
(2010)
Eur. J. Pharm. Biopharm.
, vol.74
, pp. 233-238
-
-
Visser, M.R.1
Baert, L.2
Van'T Klooster, G.3
Schueller, L.4
Geldof, M.5
Vanwelkenhuysen, I.6
De Kock, H.7
De Meyer, S.8
Frijlink, H.W.9
Rosier, J.10
Hinrichs, W.L.J.11
-
24
-
-
0242266530
-
Establishment of new preparation method for solid dispersion formulation of tacrolimus
-
K. Yamashita, T. Nakate, K. Okimoto, A. Ohike, Y. Tokunaga, R. Ibuki, K. Higaki, and T. Kimura Establishment of new preparation method for solid dispersion formulation of tacrolimus Int. J. Pharm. 267 2003 79 91
-
(2003)
Int. J. Pharm.
, vol.267
, pp. 79-91
-
-
Yamashita, K.1
Nakate, T.2
Okimoto, K.3
Ohike, A.4
Tokunaga, Y.5
Ibuki, R.6
Higaki, K.7
Kimura, T.8
-
25
-
-
52949125231
-
A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs
-
T. Yi, J. Wan, H. Xu, and X. Yang A new solid self-microemulsifying formulation prepared by spray-drying to improve the oral bioavailability of poorly water soluble drugs Eur. J. Pharm. Biopharm. 70 2008 439 444
-
(2008)
Eur. J. Pharm. Biopharm.
, vol.70
, pp. 439-444
-
-
Yi, T.1
Wan, J.2
Xu, H.3
Yang, X.4
|